JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2007-11, Vol.21 (11), p.2386-2390
Hauptverfasser:	Vicente, C, Vázquez, I, Marcotegui, N, Conchillo, A, Carranza, C, Rivell, G, Bandrés, E, Cristobal, I, Lahortiga, I, Calasanz, M J, Odero, M D
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Adolescent Adult Aged Aged, 80 and over Cancer Research Care and treatment Child Critical Care Medicine Female Gene mutations Genetic aspects Genetic Markers Health aspects Hematology Humans Intensive Internal Medicine Janus kinase 2 Janus Kinase 2 - genetics Janus Kinase 2 - physiology Karyotyping letter-to-the-editor Leukemia Leukemia, Myeloid, Acute - diagnosis Leukemia, Myeloid, Acute - genetics Male Medicine Medicine & Public Health Middle Aged Models, Genetic Mutation Oncology Prognosis Risk Risk factors Time Factors Tumor markers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!